跳到正文
心血管健康隨機試驗統合分析3 分鐘閱讀

27項試驗:糖尿病與高血壓自我管理應用可降低HbA1c和血壓

MoveVitals 編輯部 · 研究發表 · 解讀更新

原文:Effectiveness of Mobile App-Assisted Self-Care Interventions for Improving Patient Outcomes in Type 2 Diabetes and/or Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials. · JMIR mHealth and uHealth · 2020 · 論文原文 ↗

先看重點

彙總27項隨機對照試驗,手機應用輔助的自我管理與HbA1c降低(標準化均數差-0.44,95%置信區間-0.59至-0.29)以及收縮壓、舒張壓的小幅下降(標準化均數差均為-0.17)相關。效應以標準化單位表示,摘要未報告異質性。

證據類型

隨機試驗統合分析

解讀依據

公開摘要

閱讀重點

方法與適用範圍

研究在問什麼

手機應用有望支援2型糖尿病和高血壓患者的自我管理,但證據仍需加強。作者檢驗了應用輔助的自我管理能否改善患者結局,以及哪些應用功能與更好的效果相關。

研究對象與方法

遵循Cochrane協作網指南的隨機對照試驗系統綜述和統合分析。檢索MEDLINE、Cochrane圖書館、EMBASE和CINAHL Plus中2007年1月至2019年1月發表的研究。主要結局為HbA1c、收縮壓(SBP)和舒張壓(DBP)的變化,其他結局為次要結局。至少2項試驗報告的結局進行統合分析,否則做敘述性綜合。共納入27項試驗。

主要發現

以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。

  1. 1
    應用輔助的自我管理使HbA1c顯著下降(標準化均數差-0.44;95%置信區間-0.59至-0.29;P<.001)。
  2. 2
    收縮壓下降(標準化均數差-0.17;95%置信區間-0.31至-0.03;P=.02),舒張壓也下降(標準化均數差-0.17;95%置信區間-0.30至-0.03;P=.02)。
  3. 3
    在做統合分析的8項客觀次要結局中,空腹血糖和腰圍顯著下降;另有42項次要結局做了敘述性綜合,結果不一。
  4. 4
    與更好自我管理相關的功能包括血糖、血壓和用藥監測,與醫療人員溝通,自動回饋,個性化目標,提醒,健康教育和資料視覺化。

限制與不確定性

  1. 1
    效應以標準化均數差表示,難以換算成實際的HbA1c或mm Hg變化,且血壓效應較小。
  2. 2
    摘要沒有說明試驗質量和試驗間異質性,這些估計的可信度不明。
  3. 3
    關於功能的結論來自亞組分析,作為應用起效因素的證據較弱。
  4. 4
    作者指出,行為、知識和心理社會結局方面的證據仍然不足。本文解讀僅基於摘要。

日常健康啟示

對於已在管理2型糖尿病或高血壓的人,一款設計良好的自我管理應用,尤其是帶有回饋並能聯絡醫療團隊的,或許有小幅幫助。它不能替代醫療,也不能作為調整藥物的依據。使用哪些工具,可與醫師討論。

如何連結自己的資料

如果你有血糖儀或血壓計,在固定時間把讀數記入應用,並把趨勢分享給醫師,這與試驗中發現有用的功能相符。比較讀數時請使用同一裝置和同一流程,重點看整體趨勢。

如何理解這類證據

合併試驗可提高精確度,但族群、對照、偏誤與不確定性仍重要;網路排名包含間接證據,不是通用最佳方案。

作者的結構化摘要 English

以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。

Background

Mobile app-assisted self-care interventions are emerging promising tools to support self-care of patients with chronic diseases such as type 2 diabetes and hypertension. The effectiveness of such interventions requires further exploration for more supporting evidence.

Objective

A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted to examine the effectiveness of mobile app-assisted self-care interventions developed for type 2 diabetes and/or hypertension in improving patient outcomes.

Methods

We followed the Cochrane Collaboration guidelines and searched MEDLINE, Cochrane Library, EMBASE, and CINAHL Plus for relevant studies published between January 2007 and January 2019. Primary outcomes included changes in hemoglobin A_(1c) (HbA_(1c)) levels, systolic blood pressure (SBP), and diastolic blood pressure (DBP). Changes in other clinical-, behavioral-, knowledge-, and psychosocial-related outcomes were included as secondary outcomes. Primary outcomes and objective secondary outcomes that were reported in at least two trials were meta-analyzed; otherwise, a narrative synthesis was used for data analysis.

Results

A total of 27 trials were identified and analyzed. For primary outcomes, the use of mobile app-assisted self-care interventions was associated with significant reductions in HbA_(1c) levels (standardized mean difference [SMD] -0.44, 95% CI -0.59 to -0.29; P<.001), SBP (SMD -0.17, 95% CI -0.31 to -0.03, P=.02), and DBP (SMD -0.17, 95% CI -0.30 to -0.03, P=.02). Subgroup analyses for primary outcomes showed that several intervention features were supportive of self-management, including blood glucose, blood pressure, and medication monitoring, communication with health care providers, automated feedback, personalized goal setting, reminders, education materials, and data visualization. In addition, 8 objective secondary outcomes were meta-analyzed, which showed that the interventions had significant lowering effects on fasting blood glucose levels and waist circumference. A total of 42 secondary outcomes were narratively synthesized, and mixed results were found.

Conclusions

Mobile app-assisted self-care interventions can be effective tools for managing blood glucose and blood pressure, likely because their use facilitates remote management of health issues and data, provision of personalized self-care recommendations, patient-care provider communication, and decision making. More studies are required to further determine which combinations of intervention features are most effective in improving the control of the diseases. Moreover, evidence regarding the effects of these interventions on the behavioral, knowledge, and psychosocial outcomes of patients is still scarce, which warrants further examination.

來源與署名

Effectiveness of Mobile App-Assisted Self-Care Interventions for Improving Patient Outcomes in Type 2 Diabetes and/or Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Liu K, Xie Z, Or CK.

JMIR mHealth and uHealth · 2020-08-04

DOI: 10.2196/15779 ↗PubMed · 32459654 ↗Europe PMC · 所記錄的開放授權: cc by ↗

摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。

MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱

來源查核日期 2026-11-01

實用健康指南

放在一起讀

·觀察研究統合分析

晝夜活動節律紊亂與更高的死亡風險相關(109,365人)

在7項觀察性研究、共109,365名參與者中,晝夜活動對比較弱(相對振幅較低)與更高的心血管死亡風險(風險比[HR]1.50,95%置信區間1.13至1.98)和全因死亡風險(HR 1.46,95%置信區間1.27至1.68)相關。證據基礎小,又是觀察性的,不能說明改善節律就能降低風險,疾病本身也可能擾亂節律。

Journal of the American Heart Association

重點論文精講閱讀論文 →
·隨機試驗統合分析

五類運動都降低了靜息血壓,等長訓練降幅最大

彙總270項隨機試驗、共15,827名參與者的結果,有氧、抗阻、聯合、間歇和等長訓練與無介入對照組相比都降低了靜息血壓(各P<0.001),其中等長訓練降幅最大:收縮壓下降8.24 mm Hg,舒張壓下降4.00 mm Hg。各方式之間的排序部分來自間接比較,各試驗也不盡相同,所以排序不是個人的運動處方。

British Journal of Sports Medicine

重點論文精講閱讀論文 →
·隨機對照試驗

鹽替代品使中國農村高危族群的中風、主要心血管事件和死亡率下降

在中國農村600個村莊、20,995名有中風史或年齡在60歲及以上且有高血壓的人中,使用鹽替代品(氯化鈉75%、氯化鉀25%)的中風發生率低於普通鹽:平均追蹤4.74年,每1000人年29.14次對33.65次(率比0.86,95%置信區間0.77至0.96;P=0.006)。死亡也更低(率比0.88),嚴重高鉀血癥事件沒有顯著增多,但試驗為開放標籤設計,且在中國農村開展。

The New England Journal of Medicine

重點論文精講閱讀論文 →
·測量驗證研究/回顧

智慧手錶脈搏不規則提醒較少見,做貼片檢查者34%確有房顫

在419,297名沒有已知心房顫動(房顫)的蘋果手錶使用者中,0.52%收到脈搏不規則提醒;返還可用心電貼片的450人中,34%確認有房顫(97.5%置信區間29至39)。提醒發出時恰有貼片記錄的,通知的陽性預測值為0.84(95%置信區間0.76至0.92),但收到提醒者中僅20.8%返還了貼片,沒有收到提醒的人未被監測,所以手錶沒有提醒並不能排除房顫。

The New England Journal of Medicine

重點論文精講閱讀論文 →
心血管健康 →